PMC:7243778 / 30508-30846 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"769","span":{"begin":238,"end":242},"obj":"Gene"},{"id":"770","span":{"begin":327,"end":331},"obj":"Gene"},{"id":"771","span":{"begin":58,"end":68},"obj":"Species"},{"id":"772","span":{"begin":227,"end":237},"obj":"Species"},{"id":"773","span":{"begin":117,"end":122},"obj":"Species"}],"attributes":[{"id":"A769","pred":"tao:has_database_id","subj":"769","obj":"Gene:59272"},{"id":"A770","pred":"tao:has_database_id","subj":"770","obj":"Gene:59272"},{"id":"A771","pred":"tao:has_database_id","subj":"771","obj":"Tax:2697049"},{"id":"A772","pred":"tao:has_database_id","subj":"772","obj":"Tax:2697049"},{"id":"A773","pred":"tao:has_database_id","subj":"773","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Up to this moment, only few tests of specific Abs against SARS-CoV-2 have been reported. 311mab-31B5 and 311mab-32D4 human monoclonal Abs could strongly and specifically bind the RBD protein. These mAbs could efficiently block SARS-CoV-2-ACE2 interaction and neutralize pseudovirus entry into host cells ectopically expressing ACE2 [105]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T143","span":{"begin":183,"end":190},"obj":"Body_part"},{"id":"T144","span":{"begin":298,"end":303},"obj":"Body_part"}],"attributes":[{"id":"A143","pred":"fma_id","subj":"T143","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A144","pred":"fma_id","subj":"T144","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Up to this moment, only few tests of specific Abs against SARS-CoV-2 have been reported. 311mab-31B5 and 311mab-32D4 human monoclonal Abs could strongly and specifically bind the RBD protein. These mAbs could efficiently block SARS-CoV-2-ACE2 interaction and neutralize pseudovirus entry into host cells ectopically expressing ACE2 [105]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T148","span":{"begin":58,"end":66},"obj":"Disease"},{"id":"T149","span":{"begin":227,"end":235},"obj":"Disease"}],"attributes":[{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Up to this moment, only few tests of specific Abs against SARS-CoV-2 have been reported. 311mab-31B5 and 311mab-32D4 human monoclonal Abs could strongly and specifically bind the RBD protein. These mAbs could efficiently block SARS-CoV-2-ACE2 interaction and neutralize pseudovirus entry into host cells ectopically expressing ACE2 [105]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T362","span":{"begin":28,"end":33},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T363","span":{"begin":117,"end":122},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T364","span":{"begin":298,"end":303},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Up to this moment, only few tests of specific Abs against SARS-CoV-2 have been reported. 311mab-31B5 and 311mab-32D4 human monoclonal Abs could strongly and specifically bind the RBD protein. These mAbs could efficiently block SARS-CoV-2-ACE2 interaction and neutralize pseudovirus entry into host cells ectopically expressing ACE2 [105]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T170","span":{"begin":183,"end":190},"obj":"Chemical"}],"attributes":[{"id":"A170","pred":"chebi_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Up to this moment, only few tests of specific Abs against SARS-CoV-2 have been reported. 311mab-31B5 and 311mab-32D4 human monoclonal Abs could strongly and specifically bind the RBD protein. These mAbs could efficiently block SARS-CoV-2-ACE2 interaction and neutralize pseudovirus entry into host cells ectopically expressing ACE2 [105]."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T25","span":{"begin":282,"end":297},"obj":"http://purl.obolibrary.org/obo/GO_0044409"}],"text":"Up to this moment, only few tests of specific Abs against SARS-CoV-2 have been reported. 311mab-31B5 and 311mab-32D4 human monoclonal Abs could strongly and specifically bind the RBD protein. These mAbs could efficiently block SARS-CoV-2-ACE2 interaction and neutralize pseudovirus entry into host cells ectopically expressing ACE2 [105]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T237","span":{"begin":0,"end":88},"obj":"Sentence"},{"id":"T238","span":{"begin":89,"end":191},"obj":"Sentence"},{"id":"T239","span":{"begin":192,"end":338},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Up to this moment, only few tests of specific Abs against SARS-CoV-2 have been reported. 311mab-31B5 and 311mab-32D4 human monoclonal Abs could strongly and specifically bind the RBD protein. These mAbs could efficiently block SARS-CoV-2-ACE2 interaction and neutralize pseudovirus entry into host cells ectopically expressing ACE2 [105]."}